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Background: Disorders such as the metabolic syndrome (MetS), impaired glucose tolerance and diabetes, are
associated with increased risk of cognitive decline. Also several of the individual key features that define the MetS,
e.g. hypertension, impaired glucose regulation, dyslipidemia, obesity, and inflammation, are related to an increased
risk of cognitive decline. Consequently, a diet that prevents metabolic disorders might be expected to prevent
cognitive decline. The purpose of the present study was to, in overweight but otherwise healthy subjects,
investigate effects on cognitive functions of a dietary regime combining multiple functional concepts potentially
beneficial to risk markers associated with MetS. The purpose was in addition to evaluate cognitive performance in
relation to results on cardiometabolic risk variables (BMI, blood pressure, glucose, insulin, cholesterol, triglycerides,
free fatty acids, lipoprotein A-1 and B, hs-CRP, HbA1c, interleukin-6, TNF-α, and PAI-1).
Methods: Fourty-four healthy women and men (50–73 years, BMI 25–33, fasting glycemia ≤ 6.1 mmol/L)
participated in a randomized, controlled crossover intervention, comparing a multifunctional diet (active diet (AD))
including foods with a potential anti-inflammatory action, with a control diet (CD) devoid of the “active”
components. Both diets were composed in close agreement with the Nordic dietary recommendations. Each diet
was consumed during 4 wk, separated by a 4 wk washout period. Cognitive tests were performed at fasting and in
the postprandial period after a standardized breakfast, after each diet period.
Results: In comparison with the CD, the AD improved performance in the Rey Auditory-Verbal Learning test
(recognition test, p < 0.05, ANOVA, n = 42) and significantly improved performance in test of selective attention,
which also included aspects of working memory (p < 0.05, n = 40). Performance in cognitive tests was inversely
associated with plasma concentrations of cardiometabolic risk markers (fasting cholesterol, blood glucose, blood
pressure) and cardiovascular risk scores (Framingham and Reynols), and positivly associated with apolipoprotein A1
(p < 0.05).
Conclusions: The results indicate that diet characteristics may modulate cognitive performance. A relationship
seems to exist between cardiometabolic risk markers and cognitive performance in apparently healthy subjects. The
results provide additional motives for diet based prevention of metabolic disturbances related to the MetS.
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Dietary prevention is increasingly recognized as a necessary
strategy against the current epidemic of obesity and related
metabolic disorders. Epidemiological studies and dietary
interventions strongly support that high intake of whole
grain foods and legumes are beneficial in the prevention
and management of type 2 diabetes (T2DM), management
of T1DM [1], and for weight control [2]. Foods with low
glycemic index (GI) have further proven beneficial in the
prevention and treatment of the metabolic syndrome
(MetS), obesity, T2DM, and cardiovascular disease [3-6].
Other dietary measures, such as the inclusion of foods
rich in omega-3 fatty acids [7] or polyphenols (e.g. berries)
[8], have shown cardioprotective effects by improving
blood lipid profile, lowering blood pressure, and positively
affecting inflammatory markers [7,9].
Obesity, insulin resistance and T2DM are closely as-
sociated with chronic inflammation, predominately in
adipose tissue [10,11]. Interestingly, peripheral inflam-
matory cytokines can be actively transported across the
blood–brain-barrier, or induce expression of cytokines in
the brain; causing impairment of neuronal function [12,13].
Also, reduced insulin receptor signalling compromizes
neuroplasticity; indicative of a link between chronic
low grade inflammation, insulin resistance, and cognitive
impairment [14,15]. T2DM and the MetS are associated
with an increased risk of cognitive decline [16]. Conse-
quently, a diet that prevents metabolic disorders might
be expected to prevent an associated cognitive decline.
Certain foods or dietary patterns, e.g. polyphenol rich
foods (e.g. berries and cocoa) [17-19], and low GI foods
[20,21], may improve cognitive functions and/or prevent
cognitive decline. In prospective cohort- [22] and cross-
sectional [23] studies of middle aged and elderly popula-
tions, higher proportions of n-3 polyunsaturated fatty
acids (n-3 PUFA) in plasma were linked to a lower risk
of cognitive decline, and a number of studies reveal
that higher fish consumption promote better cognitive
functions [24-28]. However, few studies have examined
the possibilities to beneficially influence cardiometabolic
risk markers and measures of cognitive performance by
dietary means in apparently healthy subjects. Previously, we
reported that an “active” dietary regime, gathering differ-
ent anti-inflammatory food concepts, markedly reduced
acknowledged cardiometabolic risk markers, as well
as reduced predicted cardiovascular events in healthy
overweighed subjects (BMI, mean ± SEM: 28.5 ± 0.3 kg/m2)
[29]. The diet was e.g. rich in low glycemic impact meals,
antioxidant-rich foods, oily fish and rapeseed oil as sources
of omega-3 fatty acids, viscous dietary fibers, soybeans,
whole barley kernel products, almonds, stanols, and in-
cluded also a probiotic strain. The rationale for investi-
gating a healthy cohort was that the overall purpose of
the study relates to dietary prevention, which in shorterinterventions preferably is evaluated before manifest
metabolic diseases have been developed.
The present paper is an extension to the study described
above [29], now with the purpose to, in the same cohort,
report the impact of the active diet on measures of cogni-
tive functions. The purpose was in addition to evaluate cog-
nitive performance in relation to results on cardiometabolic
risk variables (BMI, blood pressure, glucose, insulin, choles-
terol, triglycerides, free fatty acids, lipoprotein A-1 and B,
hs-CRP, HbA1c, interleukin-6, TNF-α, and PAI-1). Fourty-
four overweight but otherwise healthy subjects (50–
73 years, BMI 25–33 kg/m2) participated in the study
(randomized controlled crossover design). The active diet
was compared with a control diet devoid of the active
components/features. Each diet was consumed during four
weeks with a four week washout period in-between.
Subjects and methods
Information regarding the subjects, diets (active and control),
and study protocol for metabolic measurements are thor-
oughly described elsewhere (J Tovar et. al. 2012 [29]), and
just briefly described in this paper. The present paper instead
focuses on new data related to the cognitive aspects.
The study was approved by the Regional Ethical Review
Board, Lund, Sweden (Dnr 593/2008).
Subjects
Inclusion criteria were age between 50 and 73 years,
BMI 25–33 kg/m2, and fasting plasma glucose concen-
tration ≤ 6.1 mmol/L. In total, 44 (36 females, 8 men)
healthy subjects between 50 and 73 years of age (mean
63.3 ± 0.8 years) without any known medical condition
or cognitive decline were included in the study. The
subjects were overweight or slightly obese, but otherwise
healthy (BMI (mean ± SEM): 28.5 ± 0.3 kg/m2). BMI of
two subjects were 25 kg/m2, 34 subjects had BMI between
25–30 kg/m2, and eight subjects had BMI 30–33 kg/m2.
More detailed description of subjects characteristics have
been presented previously [29].
Study protocol
The study had a randomized, controlled, balanced cross-
over design. One active- and one control diet were included
in the study (described below). Twenty subjects started with
the active diet and 24 subjects with the control diet. Each
diet period lasted four weeks, with a four-week washout
period in-between. The whole trial included four clinical
visits, one before and one after each diet phase. Cognitive
tests were performed after each diet period, i.e. at visits no.
two and four, whereas metabolic risk markers were deter-
mined at fasting at all four visits.
Before each intervention period (visits no. one and three),
the participants performed test versions of the Selective
Attention (SA) test and got thorough information
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(the tests are described below). No specific screening for
possible cognitive decline was carried out prior to the en-
rollment. However, performance in the pilot version of the
SA-test at visit no. one was taken as a measure of the sub-
jects' cognitive abilities to conduct the study in an ad-
equate manner. In addition the participants underwent a
medical examination at the first visit. All participants
were considered qualified to participate in the study.
At the cognitive test days (visit no. two and four), the
subjects arrived fasting in the morning between 7.30 am
and 8.15 am (individually standardized). After resting
for 15 minutes in a sitting position, physiological test
parameters were determined, including weight, blood pres-
sure, blood glucose, insulin, cholesterol (total cholesterol,
LDL (low density lipoprotein), and HDL (high density
lipoprotein)), triglycerides, free fatty acids, lipoprotein
A-1 and B, hs-CRP (high-sensitivity C-reactive protein),
HbA1c (glycated hemoglobin), inflammatory markers
(IL-6 (interleukin-6), TNF-α (tumor necrosis factor alpha)),
and PAI-1 (plasminogen activator inhibitor 1). A detailed
description of the test variables and methods used have
been presented previously [29]. The first SA-test was
performed after obtaining the fasting metabolic test
variables, and thereafter subjects were provided a stan-
dardized breakfast consisting of a white wheat bread
(75.5 g) (Dollar Storfranska, Lockarps bakery, Malmö,
Sweden) and apricot marmalade (27.7 g) (Ica, Sweden),
corresponding to 55 g available carbohydrates in total.
Water, 100 ml, and a plain cup of decaffeinated coffee
or tea (150 ml) were served with the bread. The break-
fast was supposed to be consumed within 15 min. Two
of the participants were unable to eat the whole bread
serving at the first experimental day (visit no. two).
The leftovers were weighted and registered, and the
subjects were served the same amounts of bread at the
second experimental day (visit no. four). The cognitive
tests were performed repeatedly up to 120 min after
the start of the breakfast. A time schedule for execution of
cognitive tests is presented in Table 1.Table 1 Time schedule for execution of cognitive tests
Time SA-test RAVLT-test2






1The first SA-test was performed at fasting, directly prior to a standardised
breakfast. 2The RAVLT took approximately 60 min to perform. SA selective
attention, RAVLT Rey Auditory Verbal Learning Test.Test- and control diets
The diets included (active diet and control diet) were
non vegetarian, and designed in close agreement with
the Nordic Nutrition Recommendations [30]. The active
diet contained foods, food components, and food concepts,
with documented potential to reduce sub-clinical in-
flammation and cardiometabolic risk, such as:
a) foods with high anti-oxidative capacity
(anti-inflammatory effects [31], may improve blood
pressure and blood lipids [8], suggested to be
beneficial to cognitive functions [19]).
b) fatty fish (contain long chain n-3 PUFA, known to
have anti-inflammatory and triglyceride-lowering
properties [32,33], and are suggested to improve
working memory capacity [34]). Rapeseed oil was
included to provide additional n-3-PUFA.
c) prebiotic carbohydrates intrinsic in barley kernel
products and whole grain rye foods, and products rich
in dietary fibre from oat. Included was also bread
supplemented with guar gum, which is a highly viscous
fibre. Viscous fibre (in barley, oat, and guar gum)
may lower the GI, and the indigestible
carbohydrates included in the products can have
prebiotic effects and improve glycaemic regulation,
reduce satiety, and reduce inflammatory markers
in a 10-14 h perspective [35,36].
d) Low-GI foods/meals (reduce the risk of T2DM [37]
and the MetS [38], reduce inflammatory tonus [39]
and may be beneficial to cognitive functions [20,21]).
e) products that improve the blood lipid profile
(soybeans, a margarine enriched in stanol esters, and
dry almonds [40]).
In addition the active diet included a probiotic strain
(Lactobacillus plantarum Heal19, DSM 15313) with
health benefits on the gut microflora. The control diet
contained a similar distribution of energy providing
nutrients, but essentially lacked the active food components
or food concepts.
The daily energy intake was based on gender, and
supplied 2,500-2,600 Kcal/d for men and 2,000-2,100
Kcal/d for women, including foods both from plant
and animal origin. The nutritional profiles are presented in
Table 2. The mean daily quantities of the different active
foods or food components in the active diet, and the main
functional properties that were considered for their inclu-
sion, have been summarized in Table 3. The products have
been described in more detail previously [29].
Participants were provided with a 14-day menu plan
which was repeated during the last two weeks. They had
to follow the recipes in detail for breakfast, lunch, dinner
and snacks (cooking procedures, and quantities by e.g.
weighing the food ingredients). Since the purpose was that
Table 2 Nutritional profiles of the control and active diet
Control diet Active diet
Women Men Women Men
Energy (kcal/day)* 2045 2570 2100 2615
Protein (E%) 15 14 19 18
Carbohydrate (E%) 56 55 51 50
Fat (E%) 29 30 31 31
Saturated fat (E%) 12.8 13.2 5.9 5.9
Monounsaturated fat (E%) 10.5 11.1 13.0 13.6
Polyunsaturated fat (E%) 3.6 3.7 8.2 8.4
ω-6 fatty acids (E%) 2.9 3.1 4.2 4.3
ω-3 fatty acids (E%) 0.8 0.8 2.2 2.3
ω-6/w-3 ratio 3.8 3.8 1.9 1.9
Dietary fiber (g/day) 22 26 49 61
Cholesterol (mg/day) 200 240 140 160
* Increased energy intake was prescribed for subjects that experienced weight
loss during the initial weeks (Table 2 taken from Tovar et. al. [29]).
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subjects had to weigh themselves at home once a week. If
there was a discrepancy (up or down) by more than a kg
compared with the beginning of a diet period, they were
instructed to contact a nutritionist who was attached to
the study in order to get help to adjust energy intake. They
received a check list to fill in to check off every day that
all active food components were consumed, and they had
to make a note to describe any deviation from the menu.
A limited amount of alcohol (30 and 37 g ethanol/wk for
women and men, respectively), was allowed during the
intervention period. The volunteers’ ordinary coffee and
tea drinking habits were maintained during the trial.Table 3 Proposed functional action and average content of a
Active components Main functional role
Soybean/soy protein Cholesterol-lowering, anti-inflammatory
VISCOUS FIBERS
b-glucans Cholesterol- lowering, prebiotic, GI-redu
Guar gum
Total
n-3 PUFA (20:5 + 22:6) Triglyceride-lowering, anti-inflammatory
Almonds Cholesterol-lowering [40,44]
Plant stanols Cholesterol-lowering [40,45]
Cinnamon Antioxidant [46]
Blueberries Antioxidant, prebiotic [47]
Vinegar GI –reducing [48]
Probiotic Anti-inflammatory [49]
Whey protein* GI-reducing [50]
*Whey protein (10 g) was only consumed simultaneously with high GI meals (potatCognitive tests
The rationale for the choice of cognitive tests was to
include a broad variety of aspect of cognitive functions
that are sensitive to metabolic disturbance. The SA-test
covers several domains and cognitive aspects, e.g. working
memory, attention and choice reaction time. The SA-test
is of short duration, slightly less than 10 min, and in this
respect making it suitable for repeated testing. We have
previously included the SA-test in investigations of food
effects on cognitive functions, and investigations of re-
lationships between cognitive functions and metabolic
parameters (glucose tolerance), with good results [21,51].
The time points for the SA-test were chosen to cover several
aspects with respect to glucose concentrations, and metab-
olism and its regulation; fasting stage, the postprandial peak
increase in blood glucose, and later postprandial phase. The
RAVLT took 1 hour to perform, making it difficult to repeat,
however word lists have been used extensively with respect
to investigations of cognitive effects of metabolic disorders
(e.g. Hassenstab JJ et. al 2010 [52]).
Selective attention (SA)
The test was computerized, based on spatial perception,
and primarily measured the ability to sustain a prolonged
attention, and to control and split the attention to the
entire picture on the computer screen [21,51]. The SA-test
also included aspects of the working memory i.e. simultan-
eous temporary storing and processing of information. The
SA was measured using a test made up of 96 pictures, each
shown for two seconds on the screen. The pictures
consisted of a square on a white background, divided into
four smaller squares. One of the smaller squares was red,
one was green, and two squares were uncolored (white),ctive components in the active diet
Contents in the AD (g/day)
Women Men
[40,41] 21 25









0.1 (1010 CFU) 0.1 (1010 CFU)
4.3 4.3
oes, parsnip), 3 times per week.
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subjects had to remember the positions of the colored
squares, and to compare each new picture that emerged
on the screen with the preceding one. Each time a new
picture emerged, either the green, the red or none of the
colored squares were positioned in the same position
compared with the previous picture. Within two seconds,
the subjects were supposed to indicate by pressing one of
three different keys on the keyboard, which of the three
possible alternatives that occurred for each new picture.
The SA-test was performed at fasting and at 45, and
120 minutes after start of the standardized breakfast. The
SA-test began with a short training session, and took
approximately 10 min to perform. The test was scored
with the number of correct responses (CR, total 95 credits)
and for the reaction time (RT) needed to give the response
(i.e. press one of the keys).
The Rey Auditory-Verbal Learning test (RAVLT)
The RAVLT [53] was used to measure aspects of learning
and memory. The test was modified to avoid ceiling effects.
A list of 30 common nouns (originally 15), were read to the
subjects, separated by 2 seconds, in 5 consecutive trials.
Each reading of a list was followed by an immediate free
recall where the nouns were recalled and written down on
paper within 2 minutes. Results after the 5th reading mea-
sured best learning, and the mean of trials no. 1–5 was a
measure of mean learning. In a 6th trial, an interference list
of 30 new common nouns were presented, follow by an
immediate recall (measuring proactive interference (PI) from
list 1). In a 7th trial, the subjects were supposed to recall the
first list, without a new reading (measuring retroactive inter-
ference (RI) from list 2). After a 20 minute break, in trial no.
8, without an additional reading, the subjects were asked
to again recall the first list (delayed recall). The next trial
(trial no. 9) was a recognition test. The subjects were given
a list with 100 nouns (modified from 50) of which 30 were
from the first list, 30 from the second list, and 40 were
new nouns. They were asked to, within 3 minutes, identify
the 30 words that appeared on the first list. In the last trial
(no. 10), the first list was presented on a paper in a different
order than the original list (list no. one). They were asked to
mark which words (10 nouns) that appeared fist on the ori-
ginal list, which words that appeared in the middle of the list
(10 nouns) and which were in the end of the list (10 nouns)
(memory of temporal order The test was scored for correct
recalled nouns in trials no. 1–8, mean learning (mean of
trials no. 1–5), best learning (trial no, 5), recognition (trial
no.9), and memory of temporal order (trial no. 10). The
total RAVLT took approximately 60 minutes to perform.
Calculations and statistical methods
A power calculation was performed based on cardiometabolic
test markers (plasma LDL-cholesterol and hs-CRP) inthe parallel study [29]. Based on this power calculation
it was decided to include 44 subjects. This is close to
the number of subjects (40 subjects) that have been
included in previous meal studies and interventions, using
a corresponding SA-test [21,34]. The results are expressed
as means ± SEM. The influence of the active- and control
diets on the cognitive tests was analyzed by repeated mea-
sures ANOVA at the test points, with order of diets, time
point of the test, and diets as independent variables, and
performance in cognitive tests as dependent variables.
Statistical calculations were performed in Stat View 5.0
and SuperAnova 1.11. Significant differences in cogni-
tive performance depending on diet sequence (cognitive
test day one or two) were investigate with ANOVA
(general linear model), in MINITAB Statistical Software
(release 14; Minitab, Minitab Inc, State College, PA).
Participants acted as their own control.
Multiple linear regression analysis was performed
to examine relationships between cardiometabolic risk
markers (independent variables) and performance in
cognitive tests (dependent outcome variables), using
STATA software package (release 10). A large number of
cardiometabolic risk markers were determined (described
above). To lower the number of risk markers, and to
determine and avoid multicollinearity, pair-wise rela-
tionships were examined prior to regression analyses,
using Pearson correlations in MINITAB Statistical Software
(release 14; Minitab, Minitab Inc, State College, PA).
Cardiometabolic risk markers with no tendency to be
related with cognitive performance were eliminated.
Pearson correlations in all possible pair-wise combinations
of the cardiometabolic risk markers were performed.
Five cardiometabolic risk markers (systolic blood pressure
and fasting concentrations of: total cholesterol, insulin, glu-
cose, ApoA1) were identified as non-linearly combined and
included into the multiple regression models (model no. 1).
Further backward stepwise analysis was conducted by
checking the significance of the cardiometabolic risk
markers and including in the model only those which
were statistically significant (model 2). Furthermore,
model 1 and model 2 were adjusted for age of the test
subjects (model 3 and model 4, respectively). All models
were tested for the normality of residuals. Data were
tested for outliers, and no extreme or influential data were
identified. In the case of a skewed distribution, variables
were transformed accordingly before further analyses were
performed (SA-tests: correct responses, and RAVLT: mean
of trial 1–5 and trial 8 after both active- and control diet,
and trial 7 after control diet, were analysed as their square
values, trial no. 6 were analysed as there square roots, and
cubic transformation were applied for trial no. 9 after both
the active- and control diet). Regression analyses were
based on data obtained from cognitive tests and risk
markers determined at the same visits, generating separate
Table 5 Reaction times in the SA-test after 4 weeks
consumption of the active- versus the control diet 1
SA-test (reaction time (msec)
Active diet Control diet
time 0 1320 ± 20 1320 ± 21
45 min 1219 ± 19 1230 ± 21
120 min 1182 ± 21 1202 ± 23
1 SA-test: selective attention test.
Data are given as means per treatment ± SEM, time = 0: n = 40, time = 45: n =
42, time = 120: n = 40.
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diet, respectively.
Ten-year coronary heart disease risk was calculated
with the Framingham Study equation [54], considering
age, gender, total cholesterol, HDL-cholesterol, smok-
ing and systolic BP values, and the Reynolds Risk Score
[55], which also incorporates CRP values. Relations
between Framingham- and Reynolds Risk Score and
cognitive performance were evaluated with pairwise
Pearson correlations.
Statistical evaluations of cardiometabolic risk variables
are described elsewhere [29]. Values of P < 0.05 were
considered statistically significant.
Results
Two female subjects failed to accomplish the RAVLT,
resulting in n = 42 in this test (23 subjects started with
the control diet and 19 subjects with the active diet).
Two female subjects did not participate in the SA-test,
resulting in n = 42 in the SA-test (22 subjects started
with the control diet and 20 subjects with the active diet).
Two additional female subjects dropped out from SA-test
no. 1 and SA-test no. 3 (n = 40, 21 subjects started with
the control diet and 19 subjects with the active diet).
Effects of diet on cognitive performance
SA-TESTS
No main effect depending on diet was observed in the
SA-test when all test points were included in the statistical
calculation. However, the results revealed significant time
effects and interactions (see below) making it relevant to
investigate performance in the SA-test at the different
time points. Four weeks consumption of the active diet
improved performance at 120 min in the SA-test (CR)
in comparison with the control diet (Table 4) (P < 0.05,
ANOVA, n = 40). No significant differences in RT were
detected (Table 5).
There was a significant time effect in the SA-test,
showing improved performance with time at the test
days, revealing increased CR at 45 min (73.7 ± 1.6 credits)
and 120 min (74.8 ± 1.7 credits) compared with at fastingTable 4 Correct responses in the SA-test after 4 weeks
consumption of the active- versus the control diet
SA-test1
Active diet Control diet
time 0 67.3 ± 2.5 65.6 ± 2.5
45 min 73.4 ± 2.4 74.0 ± 2.1
120 min 76.5 ± 2.4 73.1 ± 2.5*
1 SA-test: selective attention test, max 95 credits.
*: p < 0.05 for the differences in performance after the active diet in
comparison to after the control diet at 120 min. Data are given as means per
treatment ± SEM, time = 0: n = 40, time = 45: n = 42, time = 120: n = 40.(66.5 ± 1.8 credits) (P < 0.001), and decreased RT (1321 ± 14,
1224 ± 14, and 1190 ± 15 msec at time 0, 45, and 120 min
respectively, (P < 0.001). There were no main effects in
performance of SA-tests (correct responses) depending on
the consumption sequence of the diets (i.e. start with the
active diet and consume the control diet in the second
period (AC group, n = 20), or vice-versa, starting with the
control diet and consume the active diet in the last diet
period (CA group, n = 24). However, there was a significant
diet*consumption sequence interaction (P < 0.001), reveal-
ing superior performance at all test points after the active
diet compared with the control diet, when the active diet
was consumed in the second diet period (SA-test 0 min:
CR: P < 0.001, RT: P < 0.01; 45 min: CR and RT: P < 0.01,
and 120 min: CR: P < 0.001, RT: P < 0.01). The mean of
tests 0–120 min in the CA group was 77.1 ± 2.6 and
69.3 ± 2.7 credits and 1210 ± 23 and 1283 ± 20 msec after
the active- and control diet, respectively. In the AC group,
superior performance was achieved at 0 min and 45 min
after the control diet, when control diet was consumed
in the last diet period (SA-test 0 min: CR: P < 0.001,
RT: P < 0.05; 45 min: CR: P < 0.01 RT: P < 0.05). The
mean of tests 0–45 min in the AC group was 72.6 ± 3.8
and 67.2 ± 3.8 credits and 1213 ± 32 and 1273 ± 27 msec
after the control- and active diet, respectively. At 120 min
in the AC group there was a significant improved RT
after the control diet (1154 ± 32 and 1209 ± 34 msec
after the control- and active diet, respectively, P < 0.05),
but no differences in CR depending on diet (71.5 ± 4.1
and 73.4 ± 4.1 credit after active- and control diet respect-
ively, P > 0.05).
RAVLT
The trial in RAVLT measuring recognition (trial no. 9)
was significantly improved after the active diet, in com-
parison with the control diet (P < 0.05, ANOVA, n = 42),
(Table 6).
Effect of test occasion (cognitive experimental day one or two)
Improved performances were observed at the second
cognitive test day compared with the first test day in
the SA-tests (mean test no. 1–3), both in CR and RT
Table 6 Performance in the RAVLT after 4 weeks
consumption of the active- versus the control diet 1
RAVLT, trials no. 1-10
Active diet Control diet
1: List 1 12.0 ± 0.73 11.3 ± 0.64
2: List 1 16.8 ± 0.73 15.9 ± 0.80
3: List 1 20.1 ± 0.72 20.0 ± 0.75
4: List 1 21.8 ± 0.71 21.8 ± 0.77
5: List 1 (best learning) 22.7 ± 0.68 22.9 ± 0.74
1-5: List 1 (mean learning 1–5) 18.6 ± 0.65 18.4 ± 0.69
6: List 2 (PI) 9.3 ± 0.62 9.6 ± 0.70
7: List 1 (RI) 21.0 ± 0.80 20.7 ± 0.86
8: 20 min pause. List 1 21.7 ± 0.80 21.7 ± 0.95
9: List 3 (Recognition) 28.0 ± 0.51 27.2 ± 0.69*
10: List 1 (Order of listed nouns) 17.1 ± 0.64 16.0 ± 0.59
1 RAVLT: The Rey Auditory-Verbal Learning test.
*: p < 0.05 for the differences in performance in RAVLT no. 9 after the active
diet in comparison to after the control diet. Data are given as means per
treatment ± SEM, n = 42. PI proactive interference, RI retroactive interference.
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cognitive experimental day, respectively, P < 0.05; and RT:
1278 ± 16.1 and 1211 ± 18.7 msec at the first and second
cognitive experimental day, respectively, P < 0.05).
In the RAVLT, subjects performed significantly better
in trial no. 1–5 (mean) at the second test day in comparison
to the first test day (trial 1–5 (mean value): 18.0 ± 0.7 and
19.4 ± 0.6 at the first and second cognitive experimental
day, respectively, P < 0.05). A similar effect of test day
was seen in trials no. 7 (trial 7: firs test day 20.4 ± 0.8
and second test day 21.6 ± 0.8, P < 0.05).Table 7 Associations between performance in the SA-test1 (C




MODEL 1: R2: 0.28 R2: 0.35
Adj- R2: 0.17 Adj- R2: 0.26
P < 0.05 P < 0.01
MODEL 2: coef (std Err) beta coef (std Err)
Total- cholesterol −1048* (416) −0.37 53* (22)
ApoA1 - -
Systolic BP - 2.9** (0.97)
Glucose - -
Const. 9968 (1812) 638 (153)
1 SA selective attention. 2 CR correct responses, RT reaction time.
3Cardio-metabolic risk markers included in model 1 are: systolic blood pressure, fasting
includes test variables revealing significant associations with cognitive performance af
*: p < 0.05, **: p < 0.01. n = 42.Relations between cognitive performance and metabolic
risk markers
As previously have been reported [29], several metabolic
risk markers were improved after four weeks intervention
with the active diet, whereas no improvements were seen
after the control diet. Briefly, the active diet significantly im-
proved total serum cholesterol (P < 0.0001), LDL-cholesterol
(P < 0.0001), triglycerides (P < 0.01), LDL/HDL-ratio
(P < 0.0001, apoB/apoA1-ratio (P < 0.0001), HbA1c (P < 0.01),
hs-CRP (P < 0.05), and systolic blood pressure (P < 0.05). In
addition, the Framingham and the Reynolds cardiovascular
risk scores were both significantly reduced (P < 0.0001) after
the active diet, with no change after the control diet [29].
Multiple regression analyses revealed that performance on
the cognitive tests reported in this manuscript was signifi-
cantly associated with several of the cardiometabolic risk
markers; both after the active diet and the control diet
(model 1 and 2, Tables 7, 8 and 9). Regression analyses
(model 2) revealed that the number of CR in the SA-tests
after both the active- and the control diet were inversely
associated with concentrations of total cholesterol (P < 0.05,
Table 7). The RT was positively related to total cholesterol
(after the active diet, P < 0.05) and systolic blood pressure
(after active diet (P < 0.01) and control diet (P < 0.05)).
Adjusting for age in the SA-tests (CR and RT) did not
affect relationships between metabolic risk markers and
cognitive performance after the active diet, however, after
the control diet age was a stronger predictor regarding
number of CR (model 4: Coef. -131, Std- Err. 54.7, P < 0.05,
beta −0.35) than total cholesterol (ns when adjusted for age).
After the control diet both age (model 4: Coef. 9.2, Std.
Err. 3.2, P < 0.01, beta 0.39) and systolic blood pressure
(model 4: Coef. 2.5, Std. Err. 0.99, P < 0.05, beta 0.34) wereR and RT)2 and cardio-metabolic risk markers after the




R2: 0.21 R2: 0.29
Adj- R2: 0.11 Adj- R2: 0.19
P = 0.1 P < 0.05
beta coef (std Err) beta coef (std Err) beta
0.32 −535* (244) −0.33 -
- -
0.40 - 2.6* (1.1) 0.36
- -
8344 (1453) 898 (144)
concentrations of total cholesterol, Apo A-1, insulin, and glucose. Model 2
ter step-wise, one-by-one elimination of non-significant test markers in model 1.
Table 8 Associations between performance in the RAVL (trials no. 1–10) and cardio-metabolic risk markers after the active diet, obtained with regression
analyses (model 1 and model 2) 1
RAVLT, active diet












MODEL 1. R2: 0.32 R2: 0.31 R2: 0.30 R2: 0.30 R2: 0.24 R2: 0.17
Adj- R2: 0.22 Adj- R2: 0.21 Adj- R2: 0.21 Adj- R2: 0.20 Adj- R2: 0.14 Adj- R2: 0.04
P < 0.05 P < 0.05 P < 0.05 P < 0.05 P = 0.07 P = 0.29
MODEL 2. coef (std Err) beta coef (std Err) beta coef (std Err) beta coef (std Err) beta coef (std Err) beta coef (std Err) beta
Total-
cholesterol
- - - - - -
ApoA1 7.5* (3.1) 0.32 - 9.6* (3.8) 0.34 445** (157) 0.30 - 7.9* (3.3) 0.36
Systolic BP2 −0.10** (0.04) −0.40 - −0.11* (0.04) −0.37 −3.9* (1.7) −0.31 - -
Glucose - −0.44* (0.28) −0.37 - - −3576* (1449) −0.36 -
Const. 21.6 (6.6) 5.4 (0.98) 22.5 (8.0) 382 (327) 42288 (7930) 6.0 (4.7)
*: p < 0.05, **: p < 0.01. n = 43.
1 Cardio-metabolic risk markers included in model 1 are: systolic blood pressure, fasting concentrations of total cholesterol, Apo A-1, insulin, and glucose. Model 2 includes test variables revealing significant effects on





















Table 9 Associations between performance in the RAVL (trials no. 1–8)1 and cardio-metabolic risk markers after the
control diet, obtained with regression analyses (model 1 and model 2)2
RAVLT, control diet
Mean trial no. 1–5 (n = 43) Trial no. 6 (n = 41) Trial no. 7 (n = 42) Trial no. 8 (n = 42)
MODEL 1. R2: 0.18 R2: 0.19 R2: 0.30 R2: 0.35
Adj- R2: 0.16 Adj- R2: 0.06 Adj- R2: 0.21 Adj- R2: 0.25
P < 0.01 P = 0.21 P < 0.05 P < 0.01
MODEL 2. coef (std Err) beta coef (std Err) beta coef (std Err) beta coef (std Err) beta
Total cholesterol - - - - -
ApoA1 333** (109) 0.43 1.3* (0.51) 0.37 489** (142) 0.48 574*** (141) 0.54
Systolic BP3 - - - - -
Glucose - - - - -
Const. −143 (169) 1.0 (0.80) −282 (220) −363 (217)
1 Performance in trial no 9–10 did not reveal significant effects of metabolic risk markers, and the results are therefore not shown in the table.
2 Cardio-metabolic risk markers included in model 1 are systolic blood pressure, fasting concentrations of total cholesterol, Apo A-1, insulin and glucose. Model 2
includes test variables revealing significant effects on cognitive performance after step-wise, one-by-one elimination of non-significant test markers in model 1.
3 BP blood pressure.
*: p < 0.05, **: p < 0.01, ***: p < 0.0001.
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performance in the RAVLT after the active diet were
systolic blood pressure (P < 0.05-0.01) and glucose con-
centrations (P < 0.05) (inverse relationship), and Apo A-1
(positive relationship, P < 0.05-0.01), Table 8. Concentration
of Apo-A1 was also the strongest predictor to performance
in the RAVLTafter the control diet (P < 0.05-0.001, Table 9).
Further adjusting for age did not affect the results after the
active- or the control diet, with the exception that results in
RAVLT trial no. 9 tended to be stronger associated with Apo
A1 (model 4: Coef. 10604, Std. Err. 4420, P < 0.05, beta 0.34)
than glucose concentrations (ns), that was the case without
adjustment for age. Framingham- and the Reynolds cardio-
vascular risk scores to estimate 10-year cardiovascular risk
were both highly correlated with performance in nearly all
cognitive tests (Tables 10 and 11).
Discussion
The present study shows that four-week intervention
with a diet that significantly improved cardiovascular
risk variables also resulted in favorable effects on cognitiveTable 10 Pearson correlations between Reynold- and
Framingham risk scores and performance in the SA-test
(mean of tests no. 1–3)1
SA-test. mean of tests 1-3









Reynold 10 years risk −0.19 −0.18 0.32* 0.46**
Framingham 10 years
risk
−0.03 0.07 0.16 0.33*
1 SA-test selective attention test.
*: p < 0.05, **: p < 0.01.functions. Consequently, improved cognitive performance
was observed in the SA-test at 120 min post a standardized
breakfast, and in the RAVLT at approximately 115 min
(trial no. 9; recognition), after four weeks intervention with
the “active” diet compared with the control diet. In this
context, it must be noted that from a nutritional viewpoint
both the active diet and the control diet were good diets,
designed in close agreement with the Nordic Nutrition
recommendations [30]. The improved performance in the
SA-test and RAVLT (trial no. 9; recognition) were revealed
late in the test session, indicative of reduced mental
fatigue and/or increased learning capacity (the SA-test)
during the test day after the active diet compared with
the control diet.
Interestingly, in parallel to the improvements in cog-
nitive functioning, the active diet improved several
cardiometabolic risk markers connected to the MetS, e.g.
lowered cholesterol concentrations, CRP, blood pressure,
and improved measures of glucose regulation (HbA1c).
The purpose of this study was to evaluate cognitive ef-
fects of a mixed diet possessing metabolic advantageous.
Thus, the study design does not allow any conclusions
regarding effects of individual food components. However,
the major inclusion criteria for the variety of foods and
meals in the active diet were to achieve anti-inflammatory
properties through several different food mechanisms [29].
One of the underlying purposes with combining several
food concepts was to increase the possibility to include
realistic amounts of each active food components, hence
increasing compliance. When foods are investigated
individually there is often a tendency to provide active
test products in rather exaggerated amounts.
It is well established that metabolic disorders such as
the MetS, impaired glucose tolerance, and T2DM are
associated with increased risk of cognitive decline, e.g.
Table 11 Pearson correlations between Reynold- and Framingham risk scores and performance in the RAVLT no. 1–9)1
Trial no.1-5 Trial no. 6 Trial no. list 7 Trial no. list 8 Trial no. list 9
Cardiovascular risk score Active diet Control diet Active diet Control diet Active diet Control diet Active diet Active diet Active diet Control diet
Framingham risk score −0.43** −0.46** −0.29§ −0.38* −0.42** −0.37* −0.41** −0.41** −0.40** −0.42**
Reynold risk score −0.55*** −0.55*** −0.33* −0.37* −0.48** −0.48** −0.52*** −0.52*** −0.43** −0.46**
1 RAVLT: The Rey Auditory-Verbal Learning test 1–9, no significant effects were detected in trial no. 10.
*: p < 0.05, **: p < 0.01, ***: p < 0.0001, §: p < 0.1.
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information processing speed, and attention [16]. Also
several of the individual key features that define the MetS,
e.g. hypertension, impaired glucose regulation, dyslipidemia,
obesity [59], and inflammation, are related to an increased
risk of cognitive decline [60]. The results obtained in the
present study indicate that cardiometabolic risk markers
included in the MetS seem to be related to cognitive
performance also in an apparently healthy cohort,
suggesting that negative effects on cognitive functions may
occur already in an early stage of metabolic deteriorations.
Accordingly, the associations obtained in the present study
can be described such that higher levels of metabolic risk
markers (systolic blood pressure, total cholesterol, blood
glucose) were related to worse performance in cognitive
tests, meanwhile the opposite relations were obtained
between cognitive performance and the potentially pro-
tective marker Apolipoprotein A1. Considering the rela-
tively healthy study population, the results are certainly
noteworthy. Additional striking results concerning re-
lationships between cognitive performance and risk of
cardiometabolic events, were the strong associations
seen between cognitive performance and Framingham- and
the Reynolds cardiovascular risk scores to estimate 10-year
cardiovascular risk, which both were highly correlated
(Pearson correlations) with performance in nearly all
cognitive tests (Tables 10 and 11).
The test subjects in the present study can be considered
to represent a comparatively healthy cohort. In contrast,
other similar diet studies of the age matched population,
that is 50–75 years of age, typically include a hyperlipidemic
study population [40,61,62]. A recent study revealed that
the prevalence of the MetS in the Swedish population is
between 10 to 16% among 50-year-old women, 16 to 26%
among 50-year-old men, and from 20 to 35% among the
60-year-old men [63]. It was further revealed that only 5%
of that population group had no risk factors related to the
MetS. In the presently reported study, fifty-nine percent of
the volunteers exhibited no MetS-feature, and only one
could be classified as MetS-positive. Although it is widely
recognized that T2DM and the metabolic syndrome is
associated with an increased risk of cognitive decline,
the results obtained in this study points towards a tight
connection between metabolism and cognitive function
also in a healthy study population. The results suggest the
possibility of reversing cognitive decline by choice of diet,and highlight the importance of early dietary prevention.
The dietary prevention strategy should preferably include
dietary patterns aiming at lower sub-clinical inflamma-
tion and that beneficially affect several metabolic risk
markers simultaneously; which was the purpose of the
present study.
Due to the demographic profile of the population, the
age-related socioeconomic burden of brain diseases, with
or without dementia, is expected to markedly increase
during the next two decades. Dementia constitutes a
considerable part of these pathologies [64,65]. Of im-
portance in this context is that the increased preva-
lence of cardiometabolic disorders, such as T2DM and
MetS, can be expected to further increase the number
of people suffering from cognitive decline. Several lifestyle
characteristics, where diet plays an important role, are
involved in the age related cognitive decline and de-
mentia. For example, a diet rich in fat, especially of sat-
urated type, has in longitudinal population-based studies
(21 y [27] and 6 y [66] follow up), showed to be associated
with poorer performance on a variety of cognitive tasks.
Fat induced cognitive decline is probably mediated by in-
creased insulin resistance [67]. On the contrary, prospective
cohort studies indicate that diets rich in specific foods, such
as e.g. fish [25], fruits [68], and polyphenol rich berries [69],
may prevent age related cognitive decline.
In older adults with T2DM, it was noted that pharmaco-
logical interventions targeting glycemic control may im-
prove aspects of cognitive functions, e.g. working memory,
and improvements in cognitive tests were correlated with
improvement in glycemic control [70]. Furthermore, in a
two-year lifestyle intervention in T2DM with associated
cognitive impairment, some aspects of cognitive func-
tion were improved to the same level as people with
normal glucose tolerance. The intervention aimed to
improve glucose control by including group exercise
2–4 times a week as well as nutritional education with
recommendations of caloric intake, carbohydrate intake
(55 energy%), total fat intake (less than 30–35 energy%),
protein intake (10 to 15 energy%), and dietary fiber intake
(at least 30 g / day) [71]. Results obtained in the current
study provide indications of the possibility of reversing
a downward-sloping trend in cognitive performance by
diet intervention also in an apparently healthy cohort.
The present investigation was performed in middle-
aged overweight volunteers under weight maintenance
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a good proportion of the participants needed instructions
by a nutritionist not to lose weight. Overweight and
obesity are highly related to increased cardiovascular risk,
suggesting a potential for additional cognitive improve-
ments of the active diet if weight loss had been allowed.
The present study had certain limitations. One poten-
tial limitation was a possible practise effect, which was
indicated by improved performance in the SA-test and
some of the RAVLT at the second cognitive experimen-
tal day in comparison to the first experimental day.
However, the study had a well-balanced design with
respect to order of test diets, which probably eliminated
this potential limitation.
Conclusions
The present study indicates that diet characteristics may
modulate cognitive performance, and further, a relationship
appears to exist between cardiometabolic risk markers and
cognitive performance; also in apparently healthy subjects.
The results provide additional motives for diet based
prevention of metabolic disturbances related to the
metabolic syndrome.
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